TICKVALE
>⌘K
Nasdaq · CIK 0001604821 · SERVICES-MEDICAL LABORATORIES

NATERA, INC.

NTRA chart by TradingView
P/E P/B 21.4xP/SALES 14.4xEV/EBITDA FCF YIELD 0.22%

PRICE HISTORY

LIVE · NASDAQ
NTRA chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$2.3B
EBITDA
$-0.3B
FREE CASH FLOW
$0.1B
EPS
$-1.52
GROSS MARGIN
ROIC
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

P / SALES (TTM)

14.4x
+449%
LATEST · Q2 FY26
14.4xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.2x20.6x

P / BOOK

21.4x
+418%
LATEST · Q2 FY26
21.4xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.1x259.8x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

-68%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.5x14.1x

FCF YIELD (TTM)

0.22%
+11.5pp
LATEST · Q2 FY26
0.22%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-26.60%0.48%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$0.8B
+1297%
LATEST · Q2 FY26
0.8BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$-0.1B
$0.0B
LATEST · Q2 FY26
-0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$-0.1B
$0.0B
LATEST · Q2 FY26
-0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$-0.47
+$0.03
LATEST · Q2 FY26
-0.47Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

37.71%
+17.8pp
LATEST · Q2 FY26
37.71%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-24.23%64.25%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

-1.15%
+57.3pp
LATEST · Q2 FY26
-1.15%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-78.90%8.07%

RETURN ON CAPITAL

-49.5pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-105.06%-55.54%

RETURN ON EQUITY (TTM)

-10.56%
+47.0pp
LATEST · Q2 FY26
-10.56%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-2594.71%-10.56%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN
OPERATING MARGIN-10.07%
NET MARGIN-8.90%
FCF MARGIN-1.15%
70.9925.53-19.92-65.37-110.82GROSSOPERNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$-0.0B
+$0.0B
LATEST · Q2 FY26
-0.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.1B
+3757%
LATEST · Q2 FY26
0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.1B
+773%
LATEST · Q2 FY26
0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.14B
+175%
LATEST · Q2 FY26
0.14BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

+1740%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

+1%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 96.32%INSIDERS 2.87%OTHER / RETAIL 0.80%1,152 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
JPMORGAN CHASE & CO9.35%13.4M$4.31B+4.1%
Price (T.Rowe) Associates Inc8.51%12.2M$3.92B+12.1%
Blackrock Inc.7.46%10.7M$3.44B-1.7%
Vanguard Capital Management LLC4.20%6.0M$1.94BNEW
Vanguard Portfolio Management LLC3.94%5.6M$1.82BNEW
Wellington Management Group, LLP3.33%4.8M$1.54B-4.2%
State Street Corporation2.39%3.4M$1.10B+5.9%
Farallon Capital Management LLC2.24%3.2M$1.03BNEW
Duquesne Family Office Llc2.14%3.1M$986.8M+22.0%
Geode Capital Management, LLC1.94%2.8M$894.1M+6.4%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.